Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 1999

View Archived Issues

BMS discusses next-to-launch products at investor conference

IDEA obtains promising results in pilot study of transdermal insulin

Human Genome Sciences updates R&D progress

Millennium identifies key mediator of allergic immune response

Results from lead-in phase of Xcytrin trial support continued patient enrollment

Ribavirin derivative exerts potent synergistic antiviral activity

Zeffix approved in Taiwan for chronic HBV infection

Vertex commences pilot phase II study of VX-745 for rheumatoid arthritis

Tegaserod is highly effective and well tolerated in large North American study

ImClone receives payment from AHP for gonorrhea vaccine milestone

Axonyx cleared to initiate phase I clinical trials of phenserine

Merck KGaA branches out into women's healthcare with announced acquisition

Structurally modified bisphosphonate with improved activity and oral bioavailability: ISA-13-1

Pfizer downplays media hype about Viagra for women

Pliva patents novel antibiotics from the macrolide class

Agents for urinary incontinence, pollakiuria in early development at Fujisawa

Cytokine-inhibitory pyrazoles from Abbott: preparation, activity and use

Merck's new antidiabetic agents modulate insulin receptor tyrosine kinase activity

Novel antidepressants with combined 5-HT1A autoreceptor/5-HT transporter activity

Warner-Lambert-AHP merger will create world's largest pharmaceutical company

CMV retinitis in AIDS patients: HAART alone is effective

Lilly discloses methods of inhibiting multidrug resistance

Combinations of ERL-080A, RAD and/or ciclosporin prolong heart xenograft survival

Brequinar + ciclosporin for islet xenograft rejection: results using a pig-to-rat model

Beneficial effects reported for FR-167653 in rat model of myocarditis

FDA approves once-daily dosing for Videx tablets

Bradykinin B2 antagonist active in a guinea pig model of allergic bronchitis

In vivo bronchodilating, antiallergic effects documented for S-1319

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...